US Patent Issued to EyePoint Pharmaceuticals on Feb. 17 for "Bioerodible ocular drug delivery insert and therapeutic method" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,368, issued on Feb. 17, was assigned to EyePoint Pharmaceuticals Inc. (Watertown, Mass.).

"Bioerodible ocular drug delivery insert and therapeutic method" was invented by Said Saim (Watertown, Mass.), Michelle Howard-Sparks (Watertown, Mass.), Dario Paggiarino (Watertown, Mass.), Basel Karzoun (Watertown, Mass.) and Jianbing Chen (Watertown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to implantable bioerodible inserts for delivering an active pharmaceutical ingredient to the eye. The invention also relates to methods of treatment using such inserts as well as methods of manufacturing such inserts."

The patent was fi...